21 CFR Part 11 and the compliance imperative for Australian biomedical businesses

Aiden Alp
2026-10-14 9:00 am
Think Tank
Law, Policy and Global Power
Cyber Law, Regulation and Compliance

A real GAMP 5 assessment of a SharePoint QMS shows Australian biomedical manufacturers what FDA 21 CFR Part 11 demands before entering the US market.

There's More Where This Came From

Browse hundreds of sessions and build an agenda around the topics that matter to you.

Speaker in a grey suit presenting at a lectern on stage
Woman being interviewed with a Ticker microphone on the expo floor
Audience members smiling and taking photos on their phones during a session
Speaker presenting on stage against a blue and pink backdrop
Attendees wearing CyberCon headphones listening during a session
Panellists seated in white armchairs on stage during a conference discussion
Keynote speaker presenting on stage with a title slide behind him
Speaker addressing the audience with a microphone as a colleague looks on